IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma

BACKGROUND: We evaluated germline single nucleotide polymorphisms (SNPs) for association with overall survival (OS) in pazopanib- or sunitinib-treated patients with advanced renal cell carcinoma (aRCC). METHODS: The discovery analysis tested 27 SNPs within 13 genes from a phase III pazopanib trial (...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, C-F, Johnson, T, Garcia-Donas, J, Choueiri, T K, Sternberg, C N, Davis, I D, Bing, N, Deen, K C, Xue, Z, McCann, L, Esteban, E, Whittaker, J C, Spraggs, C F, Rodríguez-Antona, C, Pandite, L N, Motzer, R J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385958/
https://www.ncbi.nlm.nih.gov/pubmed/25695485
http://dx.doi.org/10.1038/bjc.2015.64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385958/
https://www.ncbi.nlm.nih.gov/pubmed/25695485
http://dx.doi.org/10.1038/bjc.2015.64

Ejemplares similares